IMMUNOGENICITY OF EXPERIMENTAL LIVE ATTENUATED JAPANESE ENCEPHALITIS VACCINE VIRUSES AND COMPARISON WITH WILD-TYPE STRAINS USING MONOCLONALAND POLYCLONAL ANTIBODIES
Bk. Sil et al., IMMUNOGENICITY OF EXPERIMENTAL LIVE ATTENUATED JAPANESE ENCEPHALITIS VACCINE VIRUSES AND COMPARISON WITH WILD-TYPE STRAINS USING MONOCLONALAND POLYCLONAL ANTIBODIES, Vaccine, 10(5), 1992, pp. 329-333
A total of 105 hybridomas secreting anti-Japanese encephalitis (JE) vi
rus monoclonal antibodies (mAbs) were generated from six fusions again
st four strains of JE virus: wild-type strains SA14 and G8924 and live
attenuated vaccines SA14-5-3 and SA14-14-2 (PDK-9). Most of the mAbs
(87%) elicited haemagglutination inhibition activity while only a mino
rity (24%) elicited neutralization. None of the mAbs prepared against
SA14-5-3, parent of SA14-14-2, elicited neutralization while the only
mAbs prepared against SA14-14-2 that elicited neutralization recognize
d flavivirus cross-reactive epitopes. In comparison, mAbs raised again
st wild-type strains showed that a spectrum of epitopes with different
specificities, including JE type-specific epitopes, elicited neutrali
zing activity. Two mAbs, prepared against SA14-5-3 virus, were found t
o be vaccine-specific and five, prepared against strains SA14 and G892
4, were wild-type-specific.